Syndax Pharmaceuticals (SNDX) EPS (Basic) (2016 - 2020)
Historic EPS (Basic) for Syndax Pharmaceuticals (SNDX) over the last 6 years, with Q4 2020 value amounting to -$0.43.
- Syndax Pharmaceuticals' EPS (Basic) rose 394.81% to -$0.43 in Q4 2020 from the same period last year, while for Dec 2020 it was -$1.55, marking a year-over-year increase of 1472.07%. This contributed to the annual value of -$3.72 for FY2024, which is 2483.22% down from last year.
- Latest data reveals that Syndax Pharmaceuticals reported EPS (Basic) of -$0.43 as of Q4 2020, which was up 394.81% from -$0.45 recorded in Q3 2020.
- In the past 5 years, Syndax Pharmaceuticals' EPS (Basic) ranged from a high of $0.79 in Q1 2018 and a low of -$2.85 during Q1 2017
- Moreover, its 5-year median value for EPS (Basic) was -$0.47 (2017), whereas its average is -$0.56.
- In the last 5 years, Syndax Pharmaceuticals' EPS (Basic) skyrocketed by 25744.68% in 2018 and then crashed by 16708.86% in 2019.
- Over the past 5 years, Syndax Pharmaceuticals' EPS (Basic) (Quarter) stood at -$0.74 in 2016, then decreased by 21.84% to -$0.91 in 2017, then grew by 15.91% to -$0.76 in 2018, then soared by 41.08% to -$0.45 in 2019, then increased by 3.95% to -$0.43 in 2020.
- Its EPS (Basic) was -$0.43 in Q4 2020, compared to -$0.45 in Q3 2020 and -$0.41 in Q2 2020.